The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients

[1]  B. Naume,et al.  Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern , 2011, Breast Cancer Research and Treatment.

[2]  M. Waltham,et al.  Epithelial-to-Mesenchymal Transitions and Circulating Tumor Cells , 2010, Journal of Mammary Gland Biology and Neoplasia.

[3]  T. Fehm,et al.  Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells , 2009, Breast Cancer Research.

[4]  S. Agelaki,et al.  Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer , 2009, British Journal of Cancer.

[5]  G. Hortobagyi,et al.  Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  D. Mavroudis,et al.  Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Funda Meric-Bernstam,et al.  HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer , 2009, Breast Cancer Research and Treatment.

[8]  W. Dalton,et al.  The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance , 2008, Clinical Cancer Research.

[9]  G. Kallergi,et al.  Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer , 2008, Clinical Cancer Research.

[10]  L. J. Veer,et al.  Towards an optimized platform for the detection, enrichment, and semi-quantitation circulating tumor cells , 2008, Breast Cancer Research and Treatment.

[11]  J. Thiery,et al.  Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  Therese Sørlie,et al.  Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer , 2007, Molecular oncology.

[13]  D. Mavroudis,et al.  Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  C. Perou,et al.  Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. , 2006, JAMA.

[15]  J. Nesland,et al.  Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer , 2006, International journal of cancer.

[16]  P. Dam,et al.  Real-time RT–PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer , 2006, British Journal of Cancer.

[17]  E. van Marck,et al.  Real-time RT–PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer , 2006, British Journal of Cancer.

[18]  T. Fehm,et al.  A pooled analysis of bone marrow micrometastasis in breast cancer. , 2005, The New England journal of medicine.

[19]  K. Pantel,et al.  Circulating Tumor Cells in Breast Cancer: Correlation to Bone Marrow Micrometastases, Heterogeneous Response to Systemic Therapy and Low Proliferative Activity , 2005, Clinical Cancer Research.

[20]  Alison Stopeck,et al.  Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Tanja Fehm,et al.  Circulating Tumor Cells in Patients with Breast Cancer Dormancy , 2004, Clinical Cancer Research.

[22]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[23]  L. J. Veer,et al.  Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers , 2004, British Journal of Cancer.

[24]  Anne Vincent-Salomon,et al.  Clinical Significance of Immunocytochemical Detection of Tumor Cells Using Digital Microscopy in Peripheral Blood and Bone Marrow of Breast Cancer Patients , 2004, Clinical Cancer Research.

[25]  G Kvalheim,et al.  Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  A. Hart,et al.  Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients , 2003, British Journal of Cancer.

[27]  I. Vlachonikolis,et al.  Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  A. Hart,et al.  Detection of circulating breast tumor cells by differential expression of marker genes. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  G Kvalheim,et al.  Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  T. Dimpfl,et al.  Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. , 2000, The New England journal of medicine.

[31]  I. Bièche,et al.  Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay. , 1999, Cancer research.

[32]  J. Nesland,et al.  Immunocytochemical detection of isolated epithelial cells in bone marrow: non‐specific staining and contribution by plasma cells directly reactive to alkaline phosphatase , 1998, The Journal of pathology.

[33]  D J Hand,et al.  Statistical methods in diagnosis , 1992, Statistical methods in medical research.

[34]  E. Galleher,et al.  CIRCULATING "CANCER CELLS". , 1964, JAMA.

[35]  G Kvalheim,et al.  Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells. , 1999, Cytotherapy.